Concepedia

Yuji Sano

YS

22

Publications

1.8K

Citations

18

H-Index

1981

Active since

Affiliations

Chugai Pharma (United States)(Current)

University of California San Diego

University of Tsukuba

Laboratory of Molecular Genetics

RIKEN BioResource Research Center

Yuji Sano is an author at Chugai Pharma (United States) specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1981–2022

22

Publications

22

ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling

Yuji Sano, Jun Harada, Shigeki Tashiro et al. · Journal of Biological Chemistry · 1999 · 344 citations · Full text

p63 induces key target genes required for epidermal morphogenesis

Maranke I. Koster, Daisy Dai, Barbara Marinari et al. · Proceedings of the National Academy of Sciences · 2007 · 229 citations · Full text

IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis

Alok Kumar Sil, Shin Maeda, Yuji Sano et al. · Nature · 2004 · 203 citations

, , +11

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

Takahiro Ishiguro, Yuji Sano, Shunichiro Komatsu et al. · Science Translational Medicine · 2017 · 195 citations

IKKα is a critical coregulator of a Smad4-independent TGFβ-Smad2/3 signaling pathway that controls keratinocyte differentiation

Pascal Descargues, Alok Kumar Sil, Yuji Sano et al. · Proceedings of the National Academy of Sciences · 2008 · 147 citations · Full text

, , +17

Rows per page

1–5 of 22